The Latest in B Cell Lymphoma

Rituximab boosts survival in primary CNS lymphoma

March 22, 2019

B Cell Lymphoma

High survival in relapsed FL after primary radiotherapy

March 21, 2019

MCL survival rates improve with novel agents

March 20, 2019

Worse survival seen among black patients with MCL

March 20, 2019

Venetoclax and obinutuzumab induces deep responses in CLL

March 18, 2019

Short telomeres predict poorer response to chemo in CLL

March 15, 2019

Bendamustine-rituximab shines in frontline treatment of MCL, iNHL

March 8, 2019

Analysis suggests ‘Burkitt-like lymphoma’ is a misnomer

March 7, 2019

B Cell Lymphoma

Gene expression signature reveals high-grade GCB DLBCL

March 2, 2019

B Cell Lymphoma

Priority review granted to lenalidomide for FL, MZL

March 2, 2019

B Cell Lymphoma

Barriers to CAR T use in the spotlight at first European meeting

February 28, 2019

B Cell Lymphoma

ZUMA-1 update: Axi-cel responses persist at 2 years

February 24, 2019

B Cell Lymphoma

Dual-targeted CAR T shows ‘clinical signal’ in NHL

February 24, 2019

Haplo-HCT shows viability in DLBCL

February 21, 2019

B Cell Lymphoma

FDA grants priority review to polatuzumab vedotin for DLBCL

February 20, 2019

B Cell Lymphoma